Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation-Reference-Cited by-同舟云学术

Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation

Published:2018-07 Issue:1 Volume:150 Page:85-91
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Kotsopoulos Joanne,Gronwald Jacek,Karlan Beth,Rosen Barry,Huzarski Tomasz,Moller Pal,Lynch Henry T.,Singer Christian F.,Senter Leigha,Neuhausen Susan L.,Tung Nadine,Eisen Andrea,Foulkes William D.,Ainsworth Peter,Sun Ping,Lubinski Jan,Narod Steven A.^ORCID

Funder

Canadian Cancer Society Research Institute

Peter Gilgan Tour de Bleu Foundation

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference14 articles.

1. Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation;Finch;J. Clin. Oncol.,2014

2. Genetic/familial high-risk assessment: breast and ovarian;National Comprehensive Cancer Network,2017

3. Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers;Kotsopoulos;Int. J. Cancer,2015

4. Bilateral oophorectomy and accelerated aging: cause or effect?;Rocca;J. Gerontol. A Biol. Sci. Med. Sci.,2017

5. Removal of all ovarian tissue versus conserving ovarian tissue at time of hysterectomy in premenopausal patients with benign disease: study using routine data and data linkage;Mytton;BMJ,2017

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of Lipid-based Nanocarriers to Improve Ovarian Cancer Treatment: An Overview of Recent Developments;Current Pharmaceutical Biotechnology;2024-12

2. Incidence of peritoneal cancer after oophorectomy among BRCA1 and BRCA2 mutation carriers;JNCI: Journal of the National Cancer Institute;2024-06-27

3. The Associations and Causal Relationships of Ovarian Cancer - Construction of a Prediction Model;International Journal of Women's Health;2024-06

4. Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations;JAMA Oncology;2024-04-01

5. Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced Ovarian Cancer in Italy;Advances in Therapy;2024-02-08